Publications

Publications by Anne Hansen Ree

59 publications found

Publications 2011

1. Bratland A, Dueland S, Hollywood D, Flatmark K, Ree AH (2011)
   Gastrointestinal toxicity of vorinostat: reanalysis of phase 1 study results with emphasis on dose-volume effects of pelvic radiotherapy
   Radiat Oncol, 6, 33
   PubMed 21473790
2. Hjortland GO, Meza-Zepeda LA, Beiske K, Ree AH, Tveito S, Hoifodt H, Bohler PJ, Hole KH, Myklebost O, Fodstad O, Smeland S, Hovig E (2011)
   Genome wide single cell analysis of chemotherapy resistant metastatic cells in a case of gastroesophageal adenocarcinoma
   BMC Cancer, 11, 455
   PubMed 22014070
3. Røe K, Kakar M, Seierstad T, Ree AH, Olsen DR (2011)
   Early prediction of response to radiotherapy and androgen-deprivation therapy in prostate cancer by repeated functional MRI: a preclinical study
   Radiat Oncol, 6, 65
   PubMed 21651782
4. Saelen MG, Flatmark K, Folkvord S, de Wijn R, Rasmussen H, Fodstad Ø, Ree AH (2011)
   Tumor kinase activity in locally advanced rectal cancer: angiogenic signaling and early systemic dissemination
   Angiogenesis, 14 (4), 481-9
   PubMed 21833622

Publications 2010

1. Bratland A, Vetrhus T, Grøholt KK, Ree AH (2010)
   Preoperative radiotherapy in rectal signet-ring cell carcinoma - magnetic resonance imaging and treatment outcome: Report of six cases
   Acta Oncol, 49 (1), 42-9
   PubMed 20100143
2. Flatmark K, Ree AH (2010)
   Radiosensitizing drugs: lessons to be learned from the oxaliplatin story
   J Clin Oncol, 28 (29), e577-8; author reply e581-3
   PubMed 20733124
3. Folkvord S, Flatmark K, Dueland S, de Wijn R, Grøholt KK, Hole KH, Nesland JM, Ruijtenbeek R, Boender PJ, Johansen M, Giercksky KE, Ree AH (2010)
   Prediction of response to preoperative chemoradiotherapy in rectal cancer by multiplex kinase activity profiling
   Int J Radiat Oncol Biol Phys, 78 (2), 555-62
   PubMed 20675069
4. Ree AH, Dueland S, Folkvord S, Hole KH, Seierstad T, Johansen M, Abrahamsen TW, Flatmark K (2010)
   Vorinostat, a histone deacetylase inhibitor, combined with pelvic palliative radiotherapy for gastrointestinal carcinoma: the Pelvic Radiation and Vorinostat (PRAVO) phase 1 study
   Lancet Oncol, 11 (5), 459-64
   PubMed 20378407
5. Røe K, Aleksandersen TB, Kristian A, Nilsen LB, Seierstad T, Qu H, Ree AH, Olsen DR, Malinen E (2010)
   Preclinical dynamic 18F-FDG PET - tumor characterization and radiotherapy response assessment by kinetic compartment analysis
   Acta Oncol, 49 (7), 914-21
   PubMed 20831478
6. Røe K, Seierstad T, Kristian A, Mikalsen LT, Mælandsmo GM, van der Kogel AJ, Ree AH, Olsen DR (2010)
   Longitudinal magnetic resonance imaging-based assessment of vascular changes and radiation response in androgen-sensitive prostate carcinoma xenografts under androgen-exposed and androgen-deprived conditions
   Neoplasia, 12 (10), 818-25
   PubMed 20927320

Publications 2009

1. Bergamaschi A, Hjortland GO, Triulzi T, Sørlie T, Johnsen H, Ree AH, Russnes HG, Tronnes S, Maelandsmo GM, Fodstad O, Borresen-Dale AL, Engebraaten O (2009)
   Molecular profiling and characterization of luminal-like and basal-like in vivo breast cancer xenograft models
   Mol Oncol, 3 (5-6), 469-82
   PubMed 19713161
2. Bratland A, Boender PJ, Høifødt HK, Østensen IH, Ruijtenbeek R, Wang MY, Berg JP, Lilleby W, Fodstad Ø, Ree AH (2009)
   Osteoblast-induced EGFR/ERBB2 signaling in androgen-sensitive prostate carcinoma cells characterized by multiplex kinase activity profiling
   Clin Exp Metastasis, 26 (5), 485-96
   PubMed 19294521
3. Folkvord S, Ree AH, Furre T, Halvorsen T, Flatmark K (2009)
   Radiosensitization by SAHA in experimental colorectal carcinoma models-in vivo effects and relevance of histone acetylation status
   Int J Radiat Oncol Biol Phys, 74 (2), 546-52
   PubMed 19427556
4. Seierstad T, Hole KH, Saelen E, Ree AH, Flatmark K, Malinen E (2009)
   MR-guided simultaneous integrated boost in preoperative radiotherapy of locally advanced rectal cancer following neoadjuvant chemotherapy
   Radiother Oncol, 93 (2), 279-84
   PubMed 19800704

Publications 2008

1. Folkvord S, Flatmark K, Seierstad T, Røe K, Rasmussen H, Ree AH (2008)
   Inhibitory effects of oxaliplatin in experimental radiation treatment of colorectal carcinoma: does oxaliplatin improve 5-fluorouracil-dependent radiosensitivity?
   Radiother Oncol, 86 (3), 428-34
   PubMed 18006097
2. Ree AH (2008)
   Highly proliferative neuroendocrine carcinoma - influence of radiotherapy fractionation on tumor response
   Radiat Oncol, 3, 13
   PubMed 18489745
3. Ree AH, Bratland A, Dueland S (2008)
   [Molecular targeted therapy in colorectal cancer]
   Tidsskr Nor Laegeforen, 128 (2), 190-3
   PubMed 18202731
4. Ree AH, Folkvord S, Flatmark K (2008)
   HDAC2 deficiency and histone acetylation
   Nat Genet, 40 (7), 812-3; author reply 813
   PubMed 18583969
5. Seierstad T, Røe K, Sitter B, Halgunset J, Flatmark K, Ree AH, Olsen DR, Gribbestad IS, Bathen TF (2008)
   Principal component analysis for the comparison of metabolic profiles from human rectal cancer biopsies and colorectal xenografts using high-resolution magic angle spinning 1H magnetic resonance spectroscopy
   Mol Cancer, 7, 33
   PubMed 18439252

Publications 2007

1. Paulsen T, Ree AH, Kaern J, Kjaerheim K, Bassarova A, Berner A, Haldorsen T, Tropé C, Nesland JM (2007)
   Expression of matrix metalloproteinase-2 in serous borderline ovarian tumors is associated with noninvasive implant formation
   Eur J Gynaecol Oncol, 28 (5), 356-63
   PubMed 17966213

Publications 2006

1. Dahm AE, Iversen N, Birkenes B, Ree AH, Sandset PM (2006)
   Estrogens, selective estrogen receptor modulators, and a selective estrogen receptor down-regulator inhibit endothelial production of tissue factor pathway inhibitor 1
   BMC Cardiovasc Disord, 6, 40
   PubMed 17029634
2. Flatmark K, Nome RV, Folkvord S, Bratland A, Rasmussen H, Ellefsen MS, Fodstad Ø, Ree AH (2006)
   Radiosensitization of colorectal carcinoma cell lines by histone deacetylase inhibition
   Radiat Oncol, 1, 25
   PubMed 16887021
3. Ree AH (2006)
   A complex case of rectal neuroendocrine carcinoma with terminal delirium
   Nat Clin Pract Gastroenterol Hepatol, 3 (7), 408-13; quiz 414
   PubMed 16819503
4. Ree AH, Stokke T, Bratland A, Patzke S, Nome RV, Folkvord S, Meza-Zepeda LA, Flatmark K, Fodstad O, Andersson Y (2006)
   DNA damage responses in cell cycle G2 phase and mitosis--tracking and targeting
   Anticancer Res, 26 (3A), 1909-16
   PubMed 16827124

Publications 2005

1. Lyng H, Landsverk KS, Kristiansen E, DeAngelis PM, Ree AH, Myklebost O, Hovig E, Stokke T (2005)
   Response of malignant B lymphocytes to ionizing radiation: gene expression and genotype
   Int J Cancer, 115 (6), 935-42
   PubMed 15723354
2. Nome RV, Bratland A, Harman G, Fodstad O, Andersson Y, Ree AH (2005)
   Cell cycle checkpoint signaling involved in histone deacetylase inhibition and radiation-induced cell death
   Mol Cancer Ther, 4 (8), 1231-8
   PubMed 16093439
3. Porojnicu AC, Robsahm TE, Ree AH, Moan J (2005)
   Season of diagnosis is a prognostic factor in Hodgkin's lymphoma: a possible role of sun-induced vitamin D
   Br J Cancer, 93 (5), 571-4
   PubMed 16136030

Publications 2004

1. DeMasters GA, Gupta MS, Jones KR, Cabot M, Wang H, Gennings C, Park M, Bratland A, Ree AH, Gewirtz DA (2004)
   Potentiation of cell killing by fractionated radiation and suppression of proliferative recovery in MCF-7 breast tumor cells by the Vitamin D3 analog EB 1089
   J Steroid Biochem Mol Biol, 92 (5), 365-74
   PubMed 15698541
2. Johansson CC, Yndestad A, Enserink JM, Ree AH, Aukrust P, Taskén K (2004)
   The epidermal growth factor-like growth factor amphiregulin is strongly induced by the adenosine 3',5'-monophosphate pathway in various cell types
   Endocrinology, 145 (11), 5177-84
   PubMed 15284208
3. Ree AH (2004)
   [Cell cycle-targeted therapy]
   Tidsskr Nor Laegeforen, 124 (19), 2479-82
   PubMed 15477884
4. Ree AH, Bratland A, Nome RV, Stokke T, Fodstad O, Andersson Y (2004)
   Inhibitory targeting of checkpoint kinase signaling overrides radiation-induced cell cycle gene regulation: a therapeutic strategy in tumor cell radiosensitization?
   Radiother Oncol, 72 (3), 305-10
   PubMed 15450729
5. Ree AH, Bratland A, Solberg Landsverk K, Fodstad O (2004)
   Ionizing radiation inhibits the PLK cell cycle gene in a G2 checkpoint-dependent manner
   Anticancer Res, 24 (2B), 555-62
   PubMed 15160994

Publications 2003

1. Bratland A, Ragnhildstveit E, Bjørnland K, Andersen K, Maelandsmo GM, Fodstad O, Saatcioglu F, Ree AH (2003)
   The metalloproteinase inhibitor TIMP-2 is down-regulated by androgens in LNCaP prostate carcinoma cells
   Clin Exp Metastasis, 20 (6), 541-7
   PubMed 14598888
2. Ree AH, Bratland A, Nome RV, Stokke T, Fodstad Ø (2003)
   Repression of mRNA for the PLK cell cycle gene after DNA damage requires BRCA1
   Oncogene, 22 (55), 8952-5
   PubMed 14654792

Publications 2002

1. Ree AH, Bratland A, Kroes RA, Aasheim HC, Flørenes VA, Moskal JR, Fodstad O, Bruland OS, Maelandsmo GM (2002)
   Clinical and cell line specific expression profiles of a human gene identified in experimental central nervous system metastases
   Anticancer Res, 22 (4), 1949-57
   PubMed 12174869
2. Ree AH, Engebraaten O, Hovig E, Fodstad Ø (2002)
   Differential display analysis of breast carcinoma cells enriched by immunomagnetic target cell selection: gene expression profiles in bone marrow target cells
   Int J Cancer, 97 (1), 28-33
   PubMed 11774240

Publications 2001

1. Bjørnland K, Bratland A, Rugnes E, Pettersen S, Johansen HT, Aasen AO, Fodstad Ø, Ree AH, Maelandsmo GM (2001)
   Expression of matrix metalloproteinases and the metastasis-associated gene S100A4 in human neuroblastoma and primitive neuroectodermal tumor cells
   J Pediatr Surg, 36 (7), 1040-4
   PubMed 11431772
2. Glauser R, Rée A, Lundgren A, Gottlow J, Hämmerle CH, Schärer P (2001)
   Immediate occlusal loading of Brånemark implants applied in various jawbone regions: a prospective, 1-year clinical study
   Clin Implant Dent Relat Res, 3 (4), 204-13
   PubMed 11887657

Publications 2000

1. Bratland A, Risberg K, Maelandsmo GM, Gützkow KB, Olsen OE, Moghaddam A, Wang MY, Hansen CM, Blomhoff HK, Berg JP, Fodstad O, Ree AH (2000)
   Expression of a novel factor, com1, is regulated by 1,25-dihydroxyvitamin D3 in breast cancer cells
   Cancer Res, 60 (19), 5578-83
   PubMed 11034106
2. Grønning LM, Wang JE, Ree AH, Haugen TB, Taskén K, Taskén KA (2000)
   Regulation of tissue inhibitor of metalloproteinases-1 in rat Sertoli cells: induction by germ cell residual bodies, interleukin-1alpha, and second messengers
   Biol Reprod, 62 (4), 1040-6
   PubMed 10727275
3. Ree AH, Pacheco MM, Tvermyr M, Fodstad O, Brentani MM (2000)
   Expression of a novel factor, com1, in early tumor progression of breast cancer
   Clin Cancer Res, 6 (5), 1778-83
   PubMed 10815897

Publications 1999

1. Ree AH, Hansson V, Walaas SI, Eskild W, Taskén KA (1999)
   Calcium/phospholipid-dependent protein kinases in rat Sertoli cells: regulation of androgen receptor messenger ribonucleic acid
   Biol Reprod, 60 (5), 1257-62
   PubMed 10208993
2. Ree AH, Tvermyr M, Engebraaten O, Rooman M, Røsok O, Hovig E, Meza-Zepeda LA, Bruland OS, Fodstad O (1999)
   Expression of a novel factor in human breast cancer cells with metastatic potential
   Cancer Res, 59 (18), 4675-80
   PubMed 10493524
3. Røsok O, Pedeutour F, Ree AH, Aasheim HC (1999)
   Identification and characterization of TESK2, a novel member of the LIMK/TESK family of protein kinases, predominantly expressed in testis
   Genomics, 61 (1), 44-54
   PubMed 10512679
4. Ståhl S, Odeberg J, Larsson M, Røsok O, Ree AH, Lundeberg J (1999)
   Solid-phase differential display and bacterial expression systems in selection and functional analysis of cDNAs
   Methods Enzymol, 303, 495-511
   PubMed 10349662

Publications 1998

1. Bjørnland K, Lehne G, Johansen HT, Fodstad O, Rugstad HE, Aasen AO, Ree AH (1998)
   Human hepatoma cells rich in P-glycoprotein display enhanced in vitro invasive properties compared to P-glycoprotein-poor hepatoma cells
   Oncol Res, 10 (5), 255-62
   PubMed 9802060
2. Ree AH, Bjørnland K, Brünner N, Johansen HT, Pedersen KB, Aasen AO, Fodstad O (1998)
   Regulation of tissue-degrading factors and in vitro invasiveness in progression of breast cancer cells
   Clin Exp Metastasis, 16 (3), 205-15
   PubMed 9568638

Publications 1997

1. Ree AH, Florenes VA, Berg JP, Maelandsmo GM, Nesland JM, Fodstad O (1997)
   High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases
   Clin Cancer Res, 3 (9), 1623-8
   PubMed 9815852

Publications 1996

1. Ree AH, Maelandsmo GM, Fodstad O (1996)
   Regulation of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in MCF-7 cells: comparison with regulatory mechanisms of pS2 expression
   Clin Exp Metastasis, 14 (4), 381-8
   PubMed 8878412

Publications 1994

1. Berg JP, Ree AH, Sandvik JA, Taskén K, Landmark BF, Torjesen PA, Haug E (1994)
   1,25-dihydroxyvitamin D3 alters the effect of cAMP in thyroid cells by increasing the regulatory subunit type II beta of the cAMP-dependent protein kinase
   J Biol Chem, 269 (51), 32233-8
   PubMed 7798223
2. Berg JP, Sandvik JA, Ree AH, Sørnes G, Bjøro T, Torjesen PA, Gordeladze JO, Haug E (1994)
   1,25-Dihydroxyvitamin D3 attenuates adenylyl cyclase activity in rat thyroid cells: reduction of thyrotropin receptor number and increase in guanine nucleotide-binding protein Gi-2 alpha
   Endocrinology, 135 (2), 595-602
   PubMed 8033808
3. Ree AH, Taskén K, Hansson V (1994)
   Regulation of glucocorticoid receptor (GR) mRNA and protein levels by phorbol ester in MCF-7 cells. Mechanism of GR mRNA induction and decay
   J Steroid Biochem Mol Biol, 48 (1), 23-9
   PubMed 8136303

Publications 1992

1. Kise NJ, Bergsmark JK, Endreseth BH, Reinertsen KV, Ugelstad TP, Ree AH (1992)
   [Living and dying alone. An epidemiological study of deaths outside institutions in Oslo in 1989]
   Tidsskr Nor Laegeforen, 112 (5), 616-9
   PubMed 1557724
2. Ree AH, Knutsen HK, Landmark BF, Eskild W, Hansson V (1992)
   Down-regulation of messenger ribonucleic acid (mRNA) for the estrogen receptor (ER) by phorbol ester requires ongoing RNA synthesis but not protein synthesis. Is hormonal control of ER mRNA degradation mediated by an RNA molecule?
   Endocrinology, 131 (4), 1810-4
   PubMed 1382961

Publications 1991

1. Eskild W, Ree AH, Levy FO, Jahnsen T, Hansson V (1991)
   Cellular localization of mRNAs for retinoic acid receptor-alpha, cellular retinol-binding protein, and cellular retinoic acid-binding protein in rat testis: evidence for germ cell-specific mRNAs
   Biol Reprod, 44 (1), 53-61
   PubMed 1849753
2. Ree AH, Landmark BF, Walaas SI, Lahooti H, Eikvar L, Eskild W, Hansson V (1991)
   Down-regulation of messenger ribonucleic acid and protein levels for estrogen receptors by phorbol ester and calcium in MCF-7 cells
   Endocrinology, 129 (1), 339-44
   PubMed 2055193

Publications 1990

1. Ree AH, Frøysa A, Eskild W, Jahnsen T, Hansson V (1990)
   Biphasic regulation of the messenger ribonucleic acid coding for the estrogen receptor by cyclic adenosine 3':5'-monophosphate in tumor Leydig cells
   Cancer Res, 50 (5), 1528-31
   PubMed 2154326

Publications 1989

1. Levy FO, Ree AH, Eikvar L, Govindan MV, Jahnsen T, Hansson V (1989)
   Glucocorticoid receptors and glucocorticoid effects in rat Sertoli cells
   Endocrinology, 124 (1), 430-6
   PubMed 2909375
2. Ree AH, Landmark BF, Eskild W, Levy FO, Lahooti H, Jahnsen T, Aakvaag A, Hansson V (1989)
   Autologous down-regulation of messenger ribonucleic acid and protein levels for estrogen receptors in MCF-7 cells: an inverse correlation to progesterone receptor levels
   Endocrinology, 124 (5), 2577-83
   PubMed 2651098